Senior Director, GTM Strategy & Portfolio Planning

12+ years of commercial biotech or pharmaceutical experience, with at least 7 years in pharmaceutical/biotech marketing

Prior people management experience required; experience building or scaling a marketing team in a launch setting strongly preferred

Rare disease launch experience required — endocrinology or nephrology experience is a significant differentiator

Demonstrated success owning brand strategy through launch, including brand planning, promotional development, and commercial execution

Proven track record leading KOL engagement programs and commercial advisory board design

Experience developing and managing both HCP and patient marketing strategies simultaneously

You are a seasoned rare disease commercialization leader who thrives at the intersection of science, strategy, and execution.

You have led — or been a critical architect of — at least one rare disease launch, and you understand that in a small-patient, high-science category, every HCP interaction and every patient touchpoint matters.

You know how to build a brand from the ground up, how to mobilize a field team around a clear and compelling narrative, and how to make the most of a narrow but deep opportunity.

The Senior Director, Head of Marketing will serve as the commercial brand authority for Calci (encaleret) — BridgeBio's oral CaSR negative allosteric modulator in NDA review for Autosomal Dominant Hypocalcemia Type 1 (ADH1).

This is a first-in-class asset targeting a chronically underserved rare endocrine population, and this role represents a defining commercial leadership opportunity.

You will own the full marketing function for Calci: leading HCP marketing, patient marketing, and KOL engagement under a single integrated brand strategy.